NeuroMetrix Inc (NURO)
4.40
+0.10
(+2.33%)
USD |
NASDAQ |
May 06, 16:00
4.39
-0.01
(-0.23%)
After-Hours: 20:00
NeuroMetrix Cash from Financing (TTM): 2.325M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.325M |
September 30, 2023 | 2.615M |
June 30, 2023 | 2.613M |
March 31, 2023 | 1.921M |
December 31, 2022 | 3.864M |
September 30, 2022 | 1.829M |
June 30, 2022 | 17.71M |
March 31, 2022 | 21.52M |
December 31, 2021 | 19.55M |
September 30, 2021 | 19.69M |
June 30, 2021 | 3.806M |
March 31, 2021 | 3.688M |
December 31, 2020 | 4.167M |
September 30, 2020 | 4.159M |
June 30, 2020 | 4.159M |
March 31, 2020 | 0.4686M |
December 31, 2019 | 0.0151M |
September 30, 2019 | 0.0169M |
June 30, 2019 | 0.0261M |
March 31, 2019 | 0.0186M |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 12.91M |
Date | Value |
---|---|
September 30, 2017 | 9.586M |
June 30, 2017 | 6.260M |
March 31, 2017 | 13.05M |
December 31, 2016 | 6.667M |
September 30, 2016 | 13.48M |
June 30, 2016 | 13.54M |
March 31, 2016 | 16.86M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | 7.137M |
September 30, 2013 | 4.501M |
June 30, 2013 | 4.567M |
March 31, 2013 | -0.0751M |
December 31, 2012 | 7.463M |
September 30, 2012 | 7.469M |
June 30, 2012 | 7.471M |
March 31, 2012 | 7.553M |
December 31, 2011 | 0.0145M |
September 30, 2011 | 0.0332M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.0151M
Minimum
Dec 2019
21.52M
Maximum
Mar 2022
6.008M
Average
3.688M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
Teleflex Inc | 60.68M |
Perspective Therapeutics Inc | 0.785M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |